OUE Healthcare Limited (SGX:5WA)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.0350
0.00 (0.00%)
At close: Jul 28, 2026

OUE Healthcare Cash Flow Statement

Millions SGD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16.87-68.054.39111.38
Depreciation & Amortization
2.952.272.161.50.88
Other Amortization
4.714.534.684.690.24
Loss (Gain) From Sale of Assets
7.542.38-0.71-
Asset Writedown & Restructuring Costs
9.8910.51-9.310.1319.89
Loss (Gain) From Sale of Investments
00.010.01-3.11-
Loss (Gain) on Equity Investments
6.15-1.28-1.691.47-12.65
Provision & Write-off of Bad Debts
0.490.260.460.13-
Other Operating Activities
40.2849.3862.7834.12-115.5
Change in Accounts Receivable
-1.755.01-2.7224.410.47
Change in Inventory
-0.19-0.14-0.08-0.48-0.08
Change in Accounts Payable
3.22-6.21.19-26.33-0.54
Operating Cash Flow
56.4160.7165.5251.624.09
Operating Cash Flow Growth
-7.09%-7.34%26.94%1161.77%303.05%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.61-0.61-0.48-0.61-0.95
Cash Acquisitions
--9.58-39.85-
Divestitures
22.44-0.080.2538.35-
Sale (Purchase) of Real Estate
-3.7529-4.92-35.34-1.1
Investment in Securities
-5.12-0.87-58.23-5.3-32.65
Other Investing Activities
-2.940.810.546.244.74
Investing Cash Flow
9.0318.68-62.8543.19-29.97

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
73.535.73191.12387.2715
Long-Term Debt Repaid
-70.63-44.79-138.13-389.03-9.86
Total Debt Repaid
-70.63-44.79-138.13-389.03-9.86
Net Debt Issued (Repaid)
2.87-9.0652.99-1.765.14
Other Financing Activities
-52.8-59.13-61.08-66.17-3.11
Financing Cash Flow
-49.94-68.2-8.09-67.932.03

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.47-0.9-1.84-3.83-1.31
Net Cash Flow
14.0310.29-7.2623.05-25.15

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
54.860.1165.0551.013.14
Free Cash Flow Growth
-8.83%-7.59%27.52%1526.04%-
Free Cash Flow Margin
35.96%40.00%40.83%42.58%15.95%
Free Cash Flow Per Share
0.010.010.010.01-
Levered Free Cash Flow
34.7829.8156.3354.11-30.91
Unlevered Free Cash Flow
45.0843.0568.2561.46-28.69

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
18.2523.8321.5214.333.11
Cash Income Tax Paid
15.0814.0312.9112.480.07
Change in Working Capital
1.28-1.33-1.61-2.41-0.15